Calamos Advisors LLC - IMMUNOMEDICS INC ownership

Quarter-by-quarter ownership
Calamos Advisors LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q4 2019$10,398,000
+58.5%
2,500,0000.0%0.05%
+41.7%
Q3 2019$6,560,000
-4.8%
2,500,0000.0%0.04%
-5.3%
Q2 2019$6,888,000
-27.7%
2,500,0000.0%0.04%
-35.6%
Q1 2019$9,530,000
+33.2%
2,500,0000.0%0.06%
+25.5%
Q4 2018$7,154,000
-30.8%
2,500,0000.0%0.05%
-17.5%
Q3 2018$10,338,000
-12.0%
2,500,0000.0%0.06%
-20.8%
Q2 2018$11,743,000
+60.3%
2,500,0000.0%0.07%
+50.0%
Q1 2018$7,324,000
-9.5%
2,500,0000.0%0.05%
+17.1%
Q4 2017$8,096,000
+14.6%
2,500,0000.0%0.04%
-25.5%
Q3 2017$7,065,0002,500,0000.06%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Castle Creek Arbitrage, LLC 5,512,000$7,743,0000.74%
Orbimed Advisors 30,000,000$42,261,0000.48%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 14,093,000$19,819,0000.29%
WOLVERINE ASSET MANAGEMENT LLC 10,010,000$14,034,0000.22%
CSS LLC/IL 1,000,000$1,408,0000.08%
Jefferies Group LLC 4,165,000$5,851,0000.04%
LAZARD ASSET MANAGEMENT LLC 13,000,000$18,354,0000.04%
PALISADE CAPITAL MANAGEMENT, LP 535,000$751,0000.03%
Citadel Advisors 13,990,000$19,718,0000.02%
AVIVA PLC 2,000,000$2,824,0000.02%
View complete list of IMMUNOMEDICS INC shareholders